Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Interventional cardiology is the branch of cardiology that specifically deals with catheter-based treatment of heart diseases, such as congenital heart defect (CHD), coronary artery disease, and aneurysm. This involves insertion of the catheter into femoral artery or any large peripheral artery or vein and through catheter whole procedure is performed by using fluoroscopy.

Statistics:

The global interventional cardiology devices market is estimated to account for US$ 27,745.6 Mn in terms of value in 2020 and is expected to reach US$ 45,754.1 Mn by the end of 2027.

Global Interventional Cardiology Devices Market: Drivers

High prevalence of cardiovascular diseases is expected to propel growth of the global interventional cardiology devices market over the forecast period. For instance, according to the American Heart Association's Heart and Stroke Statistics 2019 Update, around 48% of all adults in the U.S. suffered from some type of cardiovascular disease in 2016.   

Moreover, increasing demand for minimally invasive procedures is also expected to aid in growth of the global interventional cardiology devices market. Minimally invasive surgeries suit the patient’s preferences due to the following factors:

  • Less post-surgery complications and side effects
  • Shorter patient recovery span and minimal pain

Statistics:

Stents held dominant position in the global interventional cardiology devices market in 2019, accounting for 84.5% share in terms of value, followed by PTCA Guidewires and Angiography Catheters, respectively.

Figure 1. Global Interventional Cardiology Devices Market Share (%), by Value, by Device, 2019

Interventional Cardiology Devices  | Coherent Market Insights

Global Interventional Cardiology Devices Market: Restraints

Complications associated with interventional cardiology procedures are expected to hinder growth of the global interventional cardiology devices market. Interventional cardiology surgeries are associated with complications as listed below:

  • Stent thrombosis: formation of blood clots around the stent
  • Restenosis: Recurrence of stenosis (abnormal narrowing of an artery) post the corrective surgery
  • Some of the stents are metallic objects and prohibit the performance of an MRI scan.

Moreover, stringent approval norms and government regulations are also expected to limit the market growth. Interventional cardiology devices are categorized as high risk class III medical devices by the FDA and CE. This complicates the device approval process and makes the approval process long, stringent and expensive.

request-sample

Interventional Cardiology Devices Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 25,847.2 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 7.4% 2027 Value Projection: US$ 45,754.1 Mn
Geographies covered:
  • North America: U.S., Canada
  • Latin America: Brazil, Argentina, Mexico, Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, Rest of Middle East
  • Africa: South Africa, North Africa, Central Africa
Segments covered:
  • By Device: Angiography Catheters, IVUS, PTCA Guidewires, Guiding Catheters, Balloon Inflation Devices, Stents.
  • By End User: Hospitals, Clinics, Ambulatory Surgical Centers.
Companies covered:

Abbott Laboratories, Terumo Medical Corporation, Boston Scientific Corporation, Cardinal Health, Medtronic, Cook Medical, SINOMED, Biotronik SE & Co. KG, and B. Braun Melsungen AG.

Growth Drivers:
  • Technological advancement
  • Increasing product launches
Restraints & Challenges:
  • High costs

Global Interventional Cardiology Devices Market: Opportunities

Increasing geriatric population is expected to offer lucrative growth opportunities for players in the global interventional cardiology devices market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.     

Moreover, adoption of remote PCI procedure is also expected to aid in growth of the global interventional cardiology devices market. For instance, in December 2018, five patients located at the Apex Heart Institute in Ahmedabad, India, underwent an elective PCI procedure from a distance of roughly 20 miles (32km) away, using CorPath technology. 

The global interventional cardiology devices market was valued at US$ 25,847.2 Mn in 2019 and is forecast to reach a value of US$ 45,754.1 Mn by 2027 at a CAGR of 7.4% between 2020 and 2027.

Figure 2. Global Interventional Cardiology Devices Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027

Interventional Cardiology Devices  | Coherent Market Insights

Market Trends/Key Takeaways

Increasing number of PCI procedures is expected to aid in growth of the global interventional cardiology devices market. For instance, according to a report by National Intervention Council , India, and Apollo Health City, India, published in April 2019, a total of 3,87,416 PCI procedures were performed in 705 centers in India in 2017, which accounted for a 3.7% growth compared to that in 2016.

Major players in the global interventional cardiology devices market are focused on approval and launch of new products to expand their product portfolio. For instance, in April 2018, Terumo Corporation, a Tokyo-based medical device company, received CE mark for Ultimaster TANSEI drug-eluting stent.

Global Interventional Cardiology Devices Market: Competitive Landscape

Major players operating in the global interventional cardiology devices market include, Abbott Laboratories, Terumo Medical Corporation, Boston Scientific Corporation, Cardinal Health, Medtronic, Cook Medical, SINOMED, Biotronik SE & Co. KG, and B. Braun Melsungen AG.

Global Interventional Cardiology Devices Market: Key Developments

Major players in the global interventional cardiology devices market are focused on R&D to expand their product portfolio. For instance, in July 2019, SINOMED completed enrollment in the PIONEER III randomized, controlled clinical trial to assess the safety and effectiveness of the BuMA Supreme DES in order to obtain key regulatory approvals for the BuMA Supreme Drug-Eluting Stent (DES) System.

Interventional cardiology is the branch of cardiology that specifically deals with catheter based treatment of heart diseases, such as congenital heart defect (CHD), coronary artery disease, and aneurysm. This involves insertion of the catheter into femoral artery or any large peripheral artery or vein and through catheter whole procedure is performed by using fluoroscopy. Interventional cardiology has reduced the complications for patients as it provides, fast recovery, short hospital stay, and controlled bleeding. There is constant development in interventional cardiology devices, such as from bare metal stent to bio-absorbable stent. According to Centers for Disease Control and Prevention, which provides information about various diseases, there were around 40,000 children born with CHD in the U.S. in 2016. Interventional cardiology devices include catheters, guide wire, stents, filters, and balloons.

Restraints of the Global Interventional Cardiology Devices Market

Major factors hampering the growth of the interventional cardiology devices market during the forecast period constitutes of high costs

Key features of the study:

  • This report provides in-depth analysis of the global interventional cardiology devices market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global interventional cardiology devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Abbott Laboratories, Terumo Medical Corporation, Boston Scientific Corporation, Cardinal Health, Medtronic, Cook Medical, SINOMED, Biotronik SE & Co. KG, and B. Braun Melsungen AG.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global interventional cardiology devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Interventional Cardiology Devices Market, By Device:
    • Angiography Catheters
    • IVUS
    • PTCA Guidewires
    • Guiding Catheters
    • Balloon Inflation Devices
    • Stents
  • Global Interventional Cardiology Devices Market, By End User:
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
  • Global Interventional Cardiology Devices Market, By Geography:
    • North America
      • By Device
        • Angiography Catheters
        • IVUS
        • PTCA Guidewires
        • Guiding Catheters
        • Balloon Inflation Devices
        • Stents
      • By End User
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Device
        • Angiography Catheters
        • IVUS
        • PTCA Guidewires
        • Guiding Catheters
        • Balloon Inflation Devices
        • Stents
      • By End User
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Device
        • Angiography Catheters
        • IVUS
        • PTCA Guidewires
        • Guiding Catheters
        • Balloon Inflation Devices
        • Stents
      • By End User
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Device
        • Angiography Catheters
        • IVUS
        • PTCA Guidewires
        • Guiding Catheters
        • Balloon Inflation Devices
        • Stents
      • By End User
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East:
      • By Device
        • Angiography Catheters
        • IVUS
        • PTCA Guidewires
        • Guiding Catheters
        • Balloon Inflation Devices
        • Stents
      • By End User
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Device
        • Angiography Catheters
        • IVUS
        • PTCA Guidewires
        • Guiding Catheters
        • Balloon Inflation Devices
        • Stents
      • By End User
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
      • By Country/Region:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
    • Abbott Laboratories*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Terumo Medical Corporation
    • Boston Scientific Corporation
    • Cardinal Health
    • Medtronic Plc
    • Cook Medical
    • SINOMED
    • Biotronik SE & Co. KG
    • B. Braun Melsungen AG

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Device
      • Market Snippet, By End User
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis
    • COVID-19 Impact Analysis
  4. Global Interventional Cardiology Devices Market, By Device, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Angiography Catheters
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • IVUS
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • PTCA Guidewires
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Guiding Catheters
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Balloon Inflation Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Stents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
  5. Global Interventional Cardiology Devices Market, By End User, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Interventional Cardiology Devices Market, By Regions, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  7. Competitive Landscape
    • Company Profiles
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Terumo Medical Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Boston Scientific Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Cardinal Health
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Medtronic Plc
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Cook Medical
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • SINOMED
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Biotronik SE & Co. KG
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • B. Braun Melsungen AG
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 33 market data tables and 23 figures on “Interventional Cardiology Devices Market – Global forecast to 2027.

Frequently Asked Questions

The global interventional cardiology devices market was valued at US$ 25,847.2 Mn in 2019 and is forecast to reach a value of US$ 45,754.1 Mn by 2027 at a CAGR of 7.4% between 2020 and 2027.
Major factor driving the growth of global interventional cardiology devices market during the forecast period include technological advancement, and increasing product launches.
Major factors hampering the growth of the interventional cardiology devices market during the forecast period constitutes of high costs.
Stents held dominant position in the global interventional cardiology devices market in 2019.
North America Interventional Cardiology Devices market is expected to generate the highest revenue during the forecast period.
Some of the key players operating in the market are Abbott Laboratories, Terumo Medical Corporation, Boston Scientific Corporation, Cardinal Health, Medtronic, Cook Medical, SINOMED, Biotronik SE & Co. KG, and B. Braun Melsungen AG.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner